about
Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1alpha pathwayObesity is a fibroblast growth factor 21 (FGF21)-resistant stateEndocrine fibroblast growth factors 15/19 and 21: from feast to famineIntegrated regulation of hepatic metabolism by fibroblast growth factor 21 (FGF21) in vivoFibroblast growth factor 21: from pharmacology to physiologyBrown Fat and Browning for the Treatment of Obesity and Related Metabolic DisordersFibroblast Growth Factor Signaling in Metabolic RegulationMetabolic Effects of FGF-21: Thermoregulation and BeyondInventing new medicines: The FGF21 storyTranscriptional regulation of fibroblast growth factor 21 expressionFGF21 as a Stress Hormone: The Roles of FGF21 in Stress Adaptation and the Treatment of Metabolic DiseasesVariant Near FGF5 Has Stronger Effects on Blood Pressure in Chinese With a Higher Body Mass Index.Downstream signaling pathways in mouse adipose tissues following acute in vivo administration of fibroblast growth factor 21Bile acid sequestration reduces plasma glucose levels in db/db mice by increasing its metabolic clearance ratePlasticity in Interactions of Fibroblast Growth Factor 1 (FGF1) N Terminus with FGF Receptors Underlies Promiscuity of FGF1Fibroblast Growth Factor 21 Analogs for Treating Metabolic Disorders.Differential Role of Adipose Tissues in Obesity and Related Metabolic and Vascular ComplicationsBrown adipose tissue activity as a target for the treatment of obesity/insulin resistanceFibroblast growth factors in cardiovascular disease: The emerging role of FGF21Protein-dependent regulation of feeding and metabolismCirculating FGF21 levels are progressively increased from the early to end stages of chronic kidney diseases and are associated with renal function in ChineseA better anti-diabetic recombinant human fibroblast growth factor 21 (rhFGF21) modified with polyethylene glycolExercise increases serum fibroblast growth factor 21 (FGF21) levelsRationale-Based Engineering of a Potent Long-Acting FGF21 Analog for the Treatment of Type 2 DiabetesFGF21 requires βklotho to act in vivoRational design of a fibroblast growth factor 21-based clinical candidate, LY2405319Host-microbiome interactions: the aryl hydrocarbon receptor and the central nervous systemGenomic and metabolic responses to methionine-restricted and methionine-restricted, cysteine-supplemented diets in Fischer 344 rat inguinal adipose tissue, liver and quadriceps muscleFGF-21, a novel metabolic regulator, has a robust neuroprotective role and is markedly elevated in neurons by mood stabilizersGlucose induces FGF21 mRNA expression through ChREBP activation in rat hepatocytesFGF21 is an endocrine signal of protein restrictionFundamentals of FGF19 & FGF21 action in vitro and in vivoCharacterization of a FGF19 variant with altered receptor specificity revealed a central role for FGFR1c in the regulation of glucose metabolismFGF19 regulates cell proliferation, glucose and bile acid metabolism via FGFR4-dependent and independent pathwaysMetformin stimulates FGF21 expression in primary hepatocytes.The Role and Potential Therapeutic Implications of the Fibroblast Growth Factors in Energy Balance and Type 2 Diabetes.Exercise effects on perivascular adipose tissue: endocrine and paracrine determinants of vascular function.Promising therapies for treatment of nonalcoholic steatohepatitis.Serum FGF21 levels are associated with brown adipose tissue activity in humans.Identification of Sp1 as a Transcription Activator to Regulate Fibroblast Growth Factor 21 Gene Expression.
P2860
Q24607012-DDE30000-2D40-45A0-BAC0-303A8C074635Q24625976-141A3085-0AB4-4A02-8371-5BA661B29588Q24629260-C4699A8A-4643-4B19-A905-EB1B7A8217BBQ24632545-026D177C-1EA4-4EEF-BF3E-9928D86DE2E3Q24658126-ADE418C5-BBF7-494E-8A44-49219CF3FE25Q26766531-4B1011DF-E9D4-4B8D-814E-60F4A1F2BB2AQ26772751-A44DA4FF-C483-44BB-BDDE-68C534DBB1C4Q26781427-7E012CAE-5F8B-43AE-A88A-0858F35B83D7Q26823319-F9370E2C-3694-43A5-8F14-AAAED1776531Q27024818-C2AFF6D3-458C-4651-A488-CEFEDA4E1F0CQ27028013-CDC66562-8265-4117-AB31-C0FCEF1B05CFQ27304646-076483EF-C77A-4367-8525-FAD344261FBEQ27308344-C31A49CD-E7CB-424C-BC4D-36CED71AC889Q27321021-244E284E-CD42-4CA9-B151-0DA4F2B3952FQ27675418-D156748A-7EA1-497E-B7E8-28B3362300C7Q27686803-25D7A7E2-2EAF-4EC9-8356-E75282A2A85FQ28069452-C4F14DE9-83AE-41E9-BDA7-32F24C74444DQ28081672-CDEE1288-56E0-4310-B8F6-76BAF9938B1BQ28084197-04677498-74CB-4E4A-B85A-D9EFFADB4330Q28088330-3B92ACBB-9D66-46C2-AE7A-EDA8DE01DA22Q28477784-0DA4CB34-5FF5-4215-B8F3-280CEB4665F5Q28478454-F1D8F813-2EB7-49FC-9600-AEB757CDD336Q28484061-8A1CBD6F-2684-4883-8E8D-79DC4C16DFE5Q28485340-9A61327F-3CBB-43FF-BD9D-56897F95D53EQ28485347-033D4526-D581-464E-83DC-F2D5BF7127DFQ28487909-F25026FF-7E15-428B-8A2D-D43C0391E315Q28566343-C078FE20-8CE3-4859-AE1D-4CCDF4DCA981Q28567664-4A1A0F15-FFFE-46D0-A0F8-E5F40409ECF0Q28570740-237FAAF9-2A30-41DF-9F09-9EF57538ED7FQ28571616-85E413A2-3348-46BE-873F-BE598AD5E974Q28572009-08888DD8-D0C8-4CF5-8480-D40F4F608FAEQ28729024-8F9A91A2-0864-49D0-8D5C-0038FA7C8816Q28730955-42F9F104-ED92-4A88-B677-AF5B7FA4CAB3Q28741802-536DDF90-BD28-4B8E-A126-3811C49EE0D8Q29347106-8C57029E-EAD8-4950-8429-946B08A452D6Q30234616-A78EBCFC-FFFB-4A37-A38E-513DEC7E8AE3Q30238666-4B433871-2BDC-49AE-AADE-6E8F05D02D70Q30248578-E26E13FF-2E90-4816-99F8-E2E4F4E8F5F8Q30374773-C89A2F30-513B-4FFA-AC69-A555CB28A075Q33561352-288F8969-11A9-40C4-8D13-60C956B02297
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Fibroblast growth factor 21 corrects obesity in mice.
@ast
Fibroblast growth factor 21 corrects obesity in mice.
@en
Fibroblast growth factor 21 corrects obesity in mice.
@nl
type
label
Fibroblast growth factor 21 corrects obesity in mice.
@ast
Fibroblast growth factor 21 corrects obesity in mice.
@en
Fibroblast growth factor 21 corrects obesity in mice.
@nl
prefLabel
Fibroblast growth factor 21 corrects obesity in mice.
@ast
Fibroblast growth factor 21 corrects obesity in mice.
@en
Fibroblast growth factor 21 corrects obesity in mice.
@nl
P2093
P356
P1433
P1476
Fibroblast growth factor 21 corrects obesity in mice.
@en
P2093
Alexei Kharitonenkov
Charlie C Hu
David E Moller
Holly A Bina
James D Dunbar
Michael A Schneider
Tamer Coskun
Yanyun Chen
P304
P356
10.1210/EN.2008-0816
P407
P577
2008-08-07T00:00:00Z